Search Results 461-470 of 17391 for alopecia
Unresolved toxicity (> Grade 1 or baseline) from previous anticancer or TGCT therapy, excluding alopecia. Known active CNS metastases. History or presence ...
recovered from adverse events (other than alopecia or neuropathy) due to agents administered more than 4 weeks earlier. However, the following therapies are ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
... alopecia) and/or in whom ≥30% of the bone marrow was irradiated. Patient has had major surgery ≤14 days prior to registration or has not recovered from ...
... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation disorder ...
... alopecia or laboratory abnormalities otherwise meeting eligibility requirements. 2. Participants with clear cell, mucinous, sarcomatous (including ...
... alopecia * Platelet count >= 20,000/mm\^3 (obtained =< 14 days prior to pre-registration) * Total bilirubin =< 1.5 x upper limit of normal (ULN) (=< 3 x ULN ...
0, except for alopecia. Patients with chronic but stable Grade 2 toxicities may be allowed to enroll after an agreement between the Investigator and Sponsor ...
Our research is unique because our researchers are focused on improving the science of medicine, patient treatment and curing disease. We excel at leading the ...
... . VID-20453014. Home; General GI Marketing Video. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and technology ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.